BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Maruyama Y, Kuribara H. Overview of the Pharmacological Features of Honokiol. CNS Drug Reviews 2000;6:35-44. [DOI: 10.1111/j.1527-3458.2000.tb00136.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Guo T, Zheng B, He H, Chen L. Effects of non-covalent binding of lignans with rice starch driven by high-pressure homogenization on the starch structure and in vitro nutritional characteristics. Food Funct 2022. [PMID: 36000543 DOI: 10.1039/d2fo00798c] [Reference Citation Analysis]
2 Knežević S, Ognjanović M, Dojčinović B, Antić B, Vranješ-đurić S, Manojlović D, Stanković DM. Sensing Platform Based on Carbon Paste Electrode Modified with Bismuth Oxide Nanoparticles and SWCNT for Submicromolar Quantification of Honokiol. Food Anal Methods. [DOI: 10.1007/s12161-021-02174-2] [Reference Citation Analysis]
3 Khan PR, Mujawar T, Shekhar P, Shankar G, Subba Reddy B, Subramanyam R. Concise and practical approach for the synthesis of honokiol, a neurotrophic agent. Tetrahedron Letters 2020;61:152229. [DOI: 10.1016/j.tetlet.2020.152229] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Pulivendala G, Bale S, Godugu C. Honokiol: A polyphenol neolignan ameliorates pulmonary fibrosis by inhibiting TGF-β/Smad signaling, matrix proteins and IL-6/CD44/STAT3 axis both in vitro and in vivo. Toxicol Appl Pharmacol 2020;391:114913. [PMID: 32032644 DOI: 10.1016/j.taap.2020.114913] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
5 Banik K, Ranaware AM, Deshpande V, Nalawade SP, Padmavathi G, Bordoloi D, Sailo BL, Shanmugam MK, Fan L, Arfuso F, Sethi G, Kunnumakkara AB. Honokiol for cancer therapeutics: A traditional medicine that can modulate multiple oncogenic targets. Pharmacological Research 2019;144:192-209. [DOI: 10.1016/j.phrs.2019.04.004] [Cited by in Crossref: 93] [Cited by in F6Publishing: 87] [Article Influence: 31.0] [Reference Citation Analysis]
6 Mustafa G, Ansari SH, Bhat ZA, Abdulkareim AS. Antianxiety Activities Associated with Herbal Drugs: A Review. Plant and Human Health, Volume 3 2019. [DOI: 10.1007/978-3-030-04408-4_5] [Reference Citation Analysis]
7 Zhu X, Cai J, Zhou F, Wu Z, Li D, Li Y, Xie Z, Zhou Y, Liang Y. Genome-wide screening of budding yeast with honokiol to associate mitochondrial function with lipid metabolism. Traffic 2018;19:867-78. [PMID: 30120820 DOI: 10.1111/tra.12611] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
8 Zhu X, Zou S, Li Y, Liang Y. Transcriptomic analysis of Saccharomyces cerevisiae upon honokiol treatment. Research in Microbiology 2017;168:626-35. [DOI: 10.1016/j.resmic.2017.04.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
9 Yimam M, Jiao P, Hong M, Brownell L, Lee YC, Hyun EJ, Kim HJ, Nam JB, Kim MR, Jia Q. UP601, a standardized botanical composition composed of Morus alba, Yerba mate and Magnolia officinalis for weight loss. BMC Complement Altern Med 2017;17:114. [PMID: 28209193 DOI: 10.1186/s12906-017-1627-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
10 Bernaskova M, Schoeffmann A, Schuehly W, Hufner A, Baburin I, Hering S. Nitrogenated honokiol derivatives allosterically modulate GABAA receptors and act as strong partial agonists. Bioorg Med Chem 2015;23:6757-62. [PMID: 26410663 DOI: 10.1016/j.bmc.2015.08.034] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
11 Deng Y, Han X, Tang S, Xiao W, Tan Z, Zhou C, Wang M, Kang J. Magnolol and honokiol regulate the calcium-activated potassium channels signaling pathway in Enterotoxigenic Escherichia coli-induced diarrhea mice. European Journal of Pharmacology 2015;755:66-73. [DOI: 10.1016/j.ejphar.2015.03.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
12 Baur R, Schuehly W, Sigel E. Moderate concentrations of 4-O-methylhonokiol potentiate GABAA receptor currents stronger than honokiol. Biochim Biophys Acta 2014;1840:3017-21. [PMID: 24973566 DOI: 10.1016/j.bbagen.2014.06.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
13 Kim YJ, Choi MS, Cha BY, Woo JT, Park YB, Kim SR, Jung UJ. Long-term supplementation of honokiol and magnolol ameliorates body fat accumulation, insulin resistance, and adipose inflammation in high-fat fed mice. Mol Nutr Food Res. 2013;57:1988-1998. [PMID: 23901038 DOI: 10.1002/mnfr.201300113] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 5.9] [Reference Citation Analysis]
14 Yu HE, Oh SJ, Ryu JK, Kang JS, Hong JT, Jung JK, Han SB, Seo SY, Kim YH, Park SK, Kim HM, Lee K. Pharmacokinetics and metabolism of 4-O-methylhonokiol in rats. Phytother Res 2014;28:568-78. [PMID: 23824979 DOI: 10.1002/ptr.5033] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
15 Deporter TL, Landsberg GM, Araujo JA, Ethier JL, Bledsoe DL. Harmonease Chewable Tablets reduces noise-induced fear and anxiety in a laboratory canine thunderstorm simulation: A blinded and placebo-controlled study. Journal of Veterinary Behavior 2012;7:225-32. [DOI: 10.1016/j.jveb.2011.05.024] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
16 Lee B, Kwak JH, Huang SW, Jang JY, Lim S, Kwak YS, Lee K, Kim HS, Han SB, Hong JT, Lee H, Song S, Seo SY, Jung JK. Design and synthesis of 4-O-methylhonokiol analogs as inhibitors of cyclooxygenase-2 (COX-2) and PGF₁ production. Bioorg Med Chem 2012;20:2860-8. [PMID: 22494844 DOI: 10.1016/j.bmc.2012.03.028] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
17 Jacobo-salcedo MDR, Gonzalez-espindola LA, Alonso-castro AJ, Gonzalez-martinez MDR, Domínguez F, Garcia-carranca A. Antimicrobial Activity and Cytotoxic Effects of Magnolia dealbata and its Active Compounds. Natural Product Communications 2011;6:1934578X1100600. [DOI: 10.1177/1934578x1100600818] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
18 Alonso-castro AJ, Zapata-bustos R, Domínguez F, García-carrancá A, Salazar-olivo LA. Magnolia dealbata Zucc and its active principles honokiol and magnolol stimulate glucose uptake in murine and human adipocytes using the insulin-signaling pathway. Phytomedicine 2011;18:926-33. [DOI: 10.1016/j.phymed.2011.02.015] [Cited by in Crossref: 46] [Cited by in F6Publishing: 50] [Article Influence: 4.2] [Reference Citation Analysis]
19 Taferner B, Schuehly W, Huefner A, Baburin I, Wiesner K, Ecker GF, Hering S. Modulation of GABAA-receptors by honokiol and derivatives: subtype selectivity and structure-activity relationship. J Med Chem 2011;54:5349-61. [PMID: 21699169 DOI: 10.1021/jm200186n] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 4.3] [Reference Citation Analysis]
20 Han H, Jung JK, Han SB, Nam SY, Oh KW, Hong JT. Anxiolytic-Like Effects of 4- O- Methylhonokiol Isolated from Magnolia officinalis Through Enhancement of GABAergic Transmission and Chloride Influx. Journal of Medicinal Food 2011;14:724-31. [DOI: 10.1089/jmf.2010.1111] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
21 Zheng X, Wang X, Gou M, Zhang J, Men K, Chen L, Luo F, Zhao X, Wei Y, Qian Z. A novel transdermal honokiol formulation based on Pluronic F127 copolymer. Drug Delivery 2010;17:138-44. [DOI: 10.3109/10717541003604874] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
22 Maruyama Y, Kuribara H, Kishi E, Weintraub ST, Ito Y. Confirmation of the anxiolytic-like effect of dihydrohonokiol following behavioural and biochemical assessments. Journal of Pharmacy and Pharmacology 2001;53:721-5. [DOI: 10.1211/0022357011775848] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
23 Fang F, Gong C, Qian Z, Zhang X, Gou M, You C, Zhou L, Liu J, Zhang Y, Guo G, Gu Y, Luo F, Chen L, Zhao X, Wei Y. Honokiol nanoparticles in thermosensitive hydrogel: therapeutic effects on malignant pleural effusion. ACS Nano 2009;3:4080-8. [PMID: 19921811 DOI: 10.1021/nn900785b] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 4.0] [Reference Citation Analysis]
24 Matsui N, Takahashi K, Takeichi M, Kuroshita T, Noguchi K, Yamazaki K, Tagashira H, Tsutsui K, Okada H, Kido Y, Yasui Y, Fukuishi N, Fukuyama Y, Akagi M. Magnolol and honokiol prevent learning and memory impairment and cholinergic deficit in SAMP8 mice. Brain Research 2009;1305:108-17. [DOI: 10.1016/j.brainres.2009.09.107] [Cited by in Crossref: 77] [Cited by in F6Publishing: 80] [Article Influence: 5.9] [Reference Citation Analysis]
25 Gou M, Zheng X, Men K, Zhang J, Wang B, Lv L, Wang X, Zhao Y, Luo F, Chen L, Zhao X, Wei Y, Qian Z. Self-Assembled Hydrophobic Honokiol Loaded MPEG-PCL Diblock Copolymer Micelles. Pharm Res 2009;26:2164-73. [DOI: 10.1007/s11095-009-9929-8] [Cited by in Crossref: 53] [Cited by in F6Publishing: 59] [Article Influence: 4.1] [Reference Citation Analysis]
26 Gou M, Zheng L, Peng X, Men K, Zheng X, Zeng S, Guo G, Luo F, Zhao X, Chen L, Wei Y, Qian Z. Poly(ɛ-caprolactone)–poly(ethylene glycol)–poly(ɛ-caprolactone) (PCL–PEG–PCL) nanoparticles for honokiol delivery in vitro. International Journal of Pharmaceutics 2009;375:170-6. [DOI: 10.1016/j.ijpharm.2009.04.007] [Cited by in Crossref: 81] [Cited by in F6Publishing: 78] [Article Influence: 6.2] [Reference Citation Analysis]
27 Gou M, Li X, Dai M, Gong C, Wang X, Xie Y, Deng H, Chen L, Zhao X, Qian Z, Wei Y. A novel injectable local hydrophobic drug delivery system: Biodegradable nanoparticles in thermo-sensitive hydrogel. International Journal of Pharmaceutics 2008;359:228-33. [DOI: 10.1016/j.ijpharm.2008.03.023] [Cited by in Crossref: 92] [Cited by in F6Publishing: 96] [Article Influence: 6.6] [Reference Citation Analysis]
28 Zhou HY, Shin EM, Guo LY, Youn UJ, Bae K, Kang SS, Zou LB, Kim YS. Anti-inflammatory activity of 4-methoxyhonokiol is a function of the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via NF-κB, JNK and p38 MAPK inactivation. European Journal of Pharmacology 2008;586:340-9. [DOI: 10.1016/j.ejphar.2008.02.044] [Cited by in Crossref: 112] [Cited by in F6Publishing: 117] [Article Influence: 8.0] [Reference Citation Analysis]
29 Gou ML, Dai M, Li XY, Wang XH, Gong CY, Xie Y, Wang K, Zhao X, Qian ZY, Wei YQ. Preparation and characterization of honokiol nanoparticles. J Mater Sci: Mater Med 2008;19:2605-8. [DOI: 10.1007/s10856-007-3361-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
30 Liu B, Hattori N, Zhang N, Wu B, Yang L, Kitagawa K, Xiong Z, Irie T, Inagaki C. Anxiolytic agent, dihydrohonokiol-B, recovers amyloid β protein-induced neurotoxicity in cultured rat hippocampal neurons. Neuroscience Letters 2005;384:44-7. [DOI: 10.1016/j.neulet.2005.04.081] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
31 Zhai H, Nakade K, Oda M, Mitsumoto Y, Akagi M, Sakurai J, Fukuyama Y. Honokiol-induced neurite outgrowth promotion depends on activation of extracellular signal-regulated kinases (ERK1/2). European Journal of Pharmacology 2005;516:112-7. [DOI: 10.1016/j.ejphar.2005.04.035] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 3.0] [Reference Citation Analysis]
32 Zhang ZJ. Therapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders. Life Sci 2004;75:1659-99. [PMID: 15268969 DOI: 10.1016/j.lfs.2004.04.014] [Cited by in Crossref: 203] [Cited by in F6Publishing: 210] [Article Influence: 11.3] [Reference Citation Analysis]
33 Fukuyama Y, Nakade K, Minoshima Y, Yokoyama R, Zhai H, Mitsumoto Y. Neurotrophic activity of honokiol on the cultures of fetal rat cortical neurons. Bioorganic & Medicinal Chemistry Letters 2002;12:1163-6. [DOI: 10.1016/s0960-894x(02)00112-9] [Cited by in Crossref: 76] [Cited by in F6Publishing: 63] [Article Influence: 3.8] [Reference Citation Analysis]
34 Irie T, Miyamoto E, Kitagawa K, Maruyama Y, Inoue K, Inagaki C. An anxiolytic agent, dihydrohonokiol-B, inhibits ammonia-induced increases in the intracellular Cl− of cultured rat hippocampal neurons via GABAc receptors. Neuroscience Letters 2001;312:121-3. [DOI: 10.1016/s0304-3940(01)02201-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 0.9] [Reference Citation Analysis]
35 Kuribara H, Kishi E, Hattori N, Okada M, Maruyama Y. The anxiolytic effect of two oriental herbal drugs in Japan attributed to honokiol from magnolia bark. J Pharm Pharmacol. 2000;52:1425-1429. [PMID: 11186252 DOI: 10.1211/0022357001777432] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 2.6] [Reference Citation Analysis]